BE845518A - Agents antilipemiques a administrer par voie buccale - Google Patents

Agents antilipemiques a administrer par voie buccale

Info

Publication number
BE845518A
BE845518A BE2055272A BE2055272A BE845518A BE 845518 A BE845518 A BE 845518A BE 2055272 A BE2055272 A BE 2055272A BE 2055272 A BE2055272 A BE 2055272A BE 845518 A BE845518 A BE 845518A
Authority
BE
Belgium
Prior art keywords
administered
oral use
antilipemic agents
antilipemic
agents
Prior art date
Application number
BE2055272A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE845518A publication Critical patent/BE845518A/fr

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F22—STEAM GENERATION
    • F22B—METHODS OF STEAM GENERATION; STEAM BOILERS
    • F22B1/00—Methods of steam generation characterised by form of heating method
    • F22B1/02—Methods of steam generation characterised by form of heating method by exploitation of the heat content of hot heat carriers
    • F22B1/18—Methods of steam generation characterised by form of heating method by exploitation of the heat content of hot heat carriers the heat carrier being a hot gas, e.g. waste gas such as exhaust gas of internal-combustion engines
    • F22B1/1884—Hot gas heating tube boilers with one or more heating tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S165/00—Heat exchange
    • Y10S165/355—Heat exchange having separate flow passage for two distinct fluids
    • Y10S165/40—Shell enclosed conduit assembly
    • Y10S165/401—Shell enclosed conduit assembly including tube support or shell-side flow director
    • Y10S165/405—Extending in a longitudinal direction

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Thermal Sciences (AREA)
  • Sustainable Energy (AREA)
  • Sustainable Development (AREA)
  • Combustion & Propulsion (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heat-Exchange Devices With Radiators And Conduit Assemblies (AREA)
BE2055272A 1975-08-26 1976-08-26 Agents antilipemiques a administrer par voie buccale BE845518A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB35250/75A GB1506217A (en) 1975-08-26 1975-08-26 Oral antilipemic composition

Publications (1)

Publication Number Publication Date
BE845518A true BE845518A (fr) 1976-12-16

Family

ID=10375590

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2055272A BE845518A (fr) 1975-08-26 1976-08-26 Agents antilipemiques a administrer par voie buccale

Country Status (9)

Country Link
US (1) US4232007A (fr)
JP (1) JPS5228947A (fr)
AU (2) AU504099B2 (fr)
BE (1) BE845518A (fr)
CA (1) CA1065253A (fr)
FI (1) FI762433A7 (fr)
FR (1) FR2321898A1 (fr)
GB (1) GB1506217A (fr)
NL (1) NL166400C (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59175589U (ja) * 1983-05-12 1984-11-24 鹿浜工業株式会社 竪枠構造
CS252559B1 (en) * 1985-03-22 1987-09-17 Frantisek Rypacek Polymer stabilizer of emulsion type water in oil
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
FI925734A7 (fi) * 1991-12-20 1993-06-21 Hoechst Ag Polyaspartamidijohdoksia sappihapon adsorptioaineina, sappihappoja sisältäviä polyaspartamidijohdoksia ja menetelmä niiden valmistamiseksi sekä niiden käyttö lääkkeinä
CA2521979A1 (fr) 2003-04-09 2004-10-28 University Of Utah Research Foundation Compositions et procedes associes a la production d'erythropoietine
WO2005049050A1 (fr) * 2003-11-19 2005-06-02 Meiji Seika Kaisha, Ltd. Sialagogue et composition contenant ce compose, composition orale et composition alimentaire
JP5815928B2 (ja) * 2009-07-16 2015-11-17 花王株式会社 血中ｇｉｐ濃度上昇抑制剤
JP2011037843A (ja) * 2009-07-16 2011-02-24 Kao Corp 食後血中インスリン濃度上昇抑制剤
JP5498073B2 (ja) * 2009-07-16 2014-05-21 花王株式会社 血中トリグリセリド濃度上昇抑制剤
JP2011046647A (ja) * 2009-08-27 2011-03-10 Ajinomoto Co Inc ポリ−γ−グルタミン酸を含有するコレステロール抑制剤
JP2012144487A (ja) * 2011-01-12 2012-08-02 Kao Corp 血中トリグリセリド濃度上昇抑制剤
JP2012144484A (ja) * 2011-01-12 2012-08-02 Kao Corp 血中トリグリセリド濃度上昇抑制剤
US9056066B2 (en) 2011-01-12 2015-06-16 Kao Corporation Agent for suppressing elevation of blood GIP level, agent for suppressing elevation of blood insulin level, agent for lowering blood triglyceride level after meal ingestion, and agent for suppressing elevation of blood glucose level

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK113339B (da) * 1963-07-30 1969-03-10 Kyowa Hakko Kogyo Kk Foderstof.
US3503951A (en) * 1965-06-15 1970-03-31 Ciba Geigy Corp Complexes of a.c.t.h. peptides with polyglutamic and polyaspartic acid
US3849554A (en) * 1965-12-01 1974-11-19 Nasa Reduction of blood serum cholesterol

Also Published As

Publication number Publication date
AU1584376A (en) 1978-01-19
JPS5228947A (en) 1977-03-04
NL166400B (nl) 1981-03-16
JPS5616776B2 (fr) 1981-04-18
US4232007A (en) 1980-11-04
AU1714676A (en) 1978-03-02
FR2321898A1 (fr) 1977-03-25
GB1506217A (en) 1978-04-05
AU499744B2 (en) 1979-05-03
CA1065253A (fr) 1979-10-30
NL166400C (nl) 1981-08-17
AU504099B2 (en) 1979-10-04
FI762433A7 (fr) 1977-02-27
FR2321898B1 (fr) 1980-02-01
NL7609463A (nl) 1977-03-01

Similar Documents

Publication Publication Date Title
SE418053B (sv) Oral beredning
BE843753A (fr) Collants therapeutiques
BE852444A (fr) Compositions pharmaceutiques anti-inflammatoires
FR2301262A1 (fr) Composition anti-inflammatoire
BR7507925A (pt) Otoscopio aperfeicoado
FR2304354A1 (fr) Nouvelles compositions pharmaceutiques a activite retardee
BE845746A (fr) Compositions photopolymerisables
IT1070839B (it) Composto farmacologicamente attivi
PT65949A (pt) Pharmacologically active compounds
SE7604818L (sv) Vaccin
NO146045C (no) Oralt roentgenkontrastmiddel for cholecystangiografi
SE7905964L (sv) Dentalartikulator
BE845308A (fr) Derives d'acides phenoxy-alkylcarboxyliques
BE826935A (fr) Compositions pharmaceutiques antivirales
SE7510752L (sv) Galenisk beredning for allopyrinol-langtidsterapi
SE7608478L (sv) Farmaceutica
SE414700B (sv) Artikulator
ATA58676A (de) Zahnarztliches handstuck
SE7601072L (sv) Dentalkonstruktion
ATA245476A (de) Zahnartzliches handstuck
BE846040A (fr) Esters d'acides furanose-o-pyridylcarboxyliques
BE849872A (fr) Compositions pharmaceutiques anti-inflammatoires
SE7601566L (sv) Prostansyraderivat
BE840608A (fr) Nouvelles compositions pharmaceutiques
AR213618A1 (es) Composicion dental

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: TAIHO PHARMACEUTICAL CY LTD

Effective date: 19890831